Publications by authors named "Y Schneider"
Inpatient Nutritional Considerations in Inflammatory Bowel Disease.
Curr Gastroenterol Rep
December 2025
Article Synopsis
- This review focuses on understanding malnutrition in hospitalized patients with inflammatory bowel disease (IBD), detailing its causes, diagnosis, and treatment for both adults and children.
- Up to 85% of IBD patients experience malnutrition, leading to more health complications, longer hospital stays, and higher mortality rates.
- Early detection using tools like Subjective Global Assessment and implementing nutritional interventions such as exclusive enteral nutrition and parenteral nutrition can significantly enhance patient recovery and outcomes, necessitating further research to standardize nutritional care.
As the natural producer of acarbose, sp. SE50/110 has high industrial relevance. Like most Actinobacteria, the strain carries several more putative biosynthetic gene clusters (BGCs) to produce further natural products, which are to be discovered.
View Article and Find Full Text PDFProtective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease.
World J Gastrointest Pharmacol Ther
November 2024
Background: Inflammatory bowel disease (IBD), with its rising prevalence rates is associated with an increased risk of cardiovascular and thromboembolic events. Antiplatelets and/or anticoagulants agents are often prescribed but the literature on the impact of long-term anticoagulation and/or antiplatelet use among patients hospitalized with IBD is scarce. The aim of this study is to assess the outcomes of patients hospitalized with IBD on antiplatelet and/or anticoagulant agents.
View Article and Find Full Text PDFArticle Synopsis
- A study investigates antibacterial and antivirulence compounds derived from bacterial metabolites, specifically focusing on enteropathogenic E. coli (EPEC), a major cause of intestinal infections in infants.
- Researchers examined marine actinobacteria from the Arctic Sea for their ability to inhibit EPEC's harmful effects on intestinal cells without affecting bacterial growth.
- Key discoveries include two promising compounds: one that interferes with EPEC's ability to alter actin polymerization and another that inhibits EPEC growth, highlighting the potential of marine bacteria as sources of new antimicrobial agents.
Background: Frailty is a clinically recognizable state of increased vulnerability due to age-related decline in reserve and function across multiple physiologic systems that compromises the ability to cope with acute stress. As frailty is being identified as an important risk factor in outcomes of gastrointestinal pathologies, we aimed to assess outcomes in patients with acute pancreatitis within this cohort.
Method: We conducted a retrospective study using the Nationwide Inpatient Sample (NIS) database.